Company seeks FDA approval for MDMA as treatment for PTSD
Dec 13, 2023
“If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy, which we hope will drive additional investment into new research in mental health.”
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
Sleep problems linked to increased risk for stroke
Apr 06, 2023
The odds of stroke increased with short or long duration of sleep, impaired sleep quality, snoring, snorting and breathing cessation.
FDA approves topical treatment for molluscum contagiosum
Jul 24, 2023
Ycanth has been approved for adults and children older than 2 years.
Oral probenecid cuts time to viral clearance in COVID-19
Aug 01, 2023
The median time to viral clearance was significantly shorter for 500 and 1,000 mg probenecid versus placebo.
FDA approves new diet drug Zepbound, a version of the diabetes med Mounjaro
Nov 09, 2023
Zepbound works by activating hormone receptors in the body to reduce appetite and food intake
FDA approves new antibiotic for three indications
Apr 08, 2024
Zevtera is approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections and bacterial pneumonia.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.
First FDA-approved fecal-based treatment helps fight C. difficile
Dec 01, 2022
Rebyota is prepared from human stool donated by qualified individuals.